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Objective: Dilated common iliac arteries that complicate aortic aneurysm stent grafting usually have been managed with
endograft extension across the iliac artery bifurcation with internal iliac artery (IIA) occlusion. We studied 25 patients
with significant common iliac artery (CIA) dilation treated with two methods: endograft extension across the iliac
bifurcation or a new approach with a flared cuff within the CIA that preserves the IIA.
Methods: Of 86 patients with abdominal aortic aneurysm (AAA) who underwent bifurcated endovascular stent grafting
(ESG), 25 (29.1%) had at least one dilated CIA. Two treatment groups had different methods of management of iliac
artery dilation. Group 1 underwent ESG with straight extension across the iliac bifurcation and IIA coil embolization
before the ESG procedure (n  2) or simultaneously with ESG (n  8). Group 2 underwent ESG with flared distal cuff
(AneuRx, Medtronic AVE, Santa Rosa, Calif) contained within the CIA, the so-called “bell-bottom” procedure, thus
preserving the IIA (n  15). Iliac artery dimensions, operating room time, fluoroscopy time, and postoperative
complications were prospectively gathered.
Results: Two women and 23 men had mean diameters of AAA of 56.6 mm (range, 38 to 98 mm) and of CIA of 21.4 mm
(range, 15 to 48 mm). The diameters of CIA treated with device extension into external iliac artery after IIA coil
embolization in group 1 and with the bell-bottom procedure in group 2 were not different (mean CIA diameter, 19.9
mm; range, 15 to 26 mm; and mean, 19.1 mm; range, 15 to 24 mm; respectively). However, significantly lower operating
room and catheter procedure times were found in group 2 compared with group 1 (137 versus 192 minutes; 58 versus
106 minutes; P .02 and .02, respectively). No periprocedural type I endoleaks were found in either group. Nine patients
in group 2 also had a second contralateral CIA aneurysm, and five patients (mean CIA diameter, 33.0 mm; range, 22 to
48 mm) underwent treatment with extension across the iliac artery bifurcation and IIA occlusion. Use of the bell-bottom
procedure on the other side allowed preservation of one IIA. Four cases (mean diameter, 19.3 mm) also underwent
contralateral bell-bottom procedure. Two of these group 2 patients had complications, with severe buttock claudication
in one and distal embolism necessitating limb salvage bypass after preoperative coil embolization of the IIA in another.
Conclusion: Significant CIA ectasia or small aneurysm is often associated with AAA. In such cases, the bell-bottom
procedure that preserves IIA circulation is a new alternative to the common practice of placement of endograft extensions
across the iliac artery bifurcation in patients with at least one CIA diameter of less than 26 mm. Additional benefits
include reduced total procedure time. Early technical success appears to justify continued use. However, long-term
evaluation is necessary to determine durability because the risk of rupture as the result of potential expansion of the
excluded iliac artery or late failure is unknown. (J Vasc Surg 2002;35:874-81.)
Endovascular stent graft (ESG) repair of abdominal
aortic aneurysm (AAA) is rapidly becoming an acceptable
alternative treatment since first reported by Parodi, Palmaz,
and Barone.1 Careful patient and device selection are crit-
ically important for achieving the best results with this
technique for treatment of AAA. However, challenging
aortoiliac anatomy, such as diseased proximal neck or an-
gled tortuous vessels, is present in a significant number of
patients considered candidates for ESG. The common iliac
artery (CIA) plays a crucial role because it is the distal
attachment zone for the stent graft and must be completely
sealed to assure exclusion of the aneurysm. One or both
CIAs are dilated in 16% to 30% of ESG cases,2-7 making
them unsuitable for adequate distal sealing with commer-
cially available endovascular devices. The dilated CIA may
be ectatic or aneurysmal, more than 18 mm or greater than
50% of adjacent normal artery,8 which is larger than the
diameter of device limbs currently available.
In patients treated with ESG, limb extension into the
external iliac artery (EIA) with coil embolization of the
ipsilateral internal iliac artery (IIA) for prevention of retro-
grade endoleak into the aneurysm sac is the common
management of dilated CIA. Reports claim the relative
safety of occlusion of one or both IIAs during ESG.2,3
However, other investigators have reported serious pelvic
ischemic complications.4-7,9,10 Relocation of the iliac bifur-
cation with surgical implantion of the IIA onto the distal
EIA to preserve pelvic blood flow as proposed by Parodi
and Ferreira11 is another option for management of dilated
CIA. Another less invasive method is use of a flared cuff, the
so-called “bell-bottom” technique, that anchors the device
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within the CIA, thus preserving IIA patency.12 A short
aortic extension cuff is used in the distal CIA attachment
zone to achieve a complete seal.
We reviewed our experience with ESG treatment of
patients with AAA who had significant unilateral or bilateral
CIA dilation (15 mm) with two methods, endograft
extension across the iliac bifurcation with IIA coil emboli-
zation and bell-bottom technique. The purpose of this
study was to compare the feasibility and outcome, particu-
larly pelvic ischemia symptoms, of the patients treated with
both techniques and also the operating room (OR), cath-
eter procedure, and fluoroscopic times.
METHODS
From August 1997 to April 2001, 86 patients with
AAA underwent treatment with ESG. At least one signifi-
cantly dilated CIA (15 mm) was found in 25 patients
(29.1%), 16 unilateral and nine bilateral. The two treat-
ment groups were group 1, ESG with extension across the
iliac bifurcation and IIA coil embolization (10 cases), and
group 2, ESG with so-called bell-bottom procedure (15
cases, nine bilateral). The bell-bottom procedure uses an
aortic extender cuff (AneuRx, Medtronic AVE, Santa Rosa,
Calif) as a flared distal cuff within the CIA to preserve blood
flow to the IIA (Fig 1). A total of 19 bell-bottom proce-
dures (11 unilateral and 4 bilateral) were performed. Coil
embolization of one IIA was performed in all group 1 cases.
Five patients in group 2 underwent contralateral IIA coil
embolization in addition to the bell-bottom procedure.
All patients underwent evaluation with spiral computed
tomographic (CT) scanning with 2-mm reconstruction
interval axial slices. The details of the preprocedural imag-
ing methods and the inclusion criteria of the patients were
described elsewhere.13 Two endograft systems were used in
these 25 patients: AneuRx (Medtronic AVE; n  17) and
Vanguard (Boston Scientific/Vascular, Natick, Mass; n 
8). Before January 2000, all AAA cases with bilateral dilated
CIA were excluded from ESG treatment, and AAA cases
with unilateral dilated CIA, which were eligible for ESG,
were treated with coil embolization of IIA and limb exten-
sion into EIA, preserving one contralateral patent IIA.
Eight patients in group 1 received the Vanguard device,
and two received AneuRx. All group 2 patients underwent
treatment with AneuRx devices, which became commer-
cially available after January 2000. Bilateral bell-bottom
procedures were used in four of the nine patients in group
2 who had bilateral dilated CIA (Fig 2), and bell-bottom
procedure on one side and IIA coil embolization with
device extension into EIA was used in five patients (Fig 3).
No patients underwent bilateral IIA coil occlusion.
Occurrence of the following conventional comorbidi-
ties was not significantly different between group 1 and
group 2, respectively: current or former smoker (80% ver-
sus 80%), preexisting heart disease (47% versus 50%), hy-
pertension (53% versus 60%), and hyperlipidemia (67%
versus 50%; P .4 for all). Less common associated comor-
bidities in group 1 and group 2, respectively, were diabetes
mellitus (20% versus 10%), chronic obstructive pulmonary
disease (33% versus 20%), and renal dysfunction (13% ver-
sus 0; P  .23 for all).
Six patients underwent IIA coil embolization before
surgery, two cases in group 1 and four cases in group 2. Coil
embolization of the IIA with Gianturco coils (Cook,
Bloomington, Ind) was performed via the contralateral
femoral artery approach. No aneurysmal IIAs were treated.
Total occlusion of the IIA was achieved in all cases. One
case in group 2 had distal emboli after the procedure that
necessitated a limb salvage procedure and had ESG 3
months later. The other five patients underwent IIA coil
embolization an average of 17 days before ESG. Emboli-
zation of the IIA was done at its origin, proximal to anterior
and posterior bifurcation, permitting distal collateral circu-
lation to remain patent. The IIA coil embolization proce-
dures were done before surgery in the most recently treated
cases to allow collateral blood flow development in the
event that the bell-bottom procedure failed and the re-
maining IIA occluded.
The aortic extension cuff size (available diameters, 20,
22, 24, 26, and 28 mm; 37.5 mm long) was selected on the
basis of the diameter of the planned attachment zone of the
CIA. Oversizing of the cuff by 10% to 20% was used. A
length of 15-mm to 17.5-mm distal contact between the
extension cuff and the CIA was considered adequate for
attachment and sealing with 20-mm length of the cuff
proximally apposed within the endograft limb.
Preoperative aortoiliac dimensions, including AAA and
CIA diameters, the diameter of the extension cuff used, OR
time (the total time used from the beginning of skin inci-
sion to the finish of skin closure), catheter procedure time
(the total time from insertion of the first catheter to with-
drawal of the last catheter), fluoroscopy time, and postop-
erative complications were prospectively gathered. The flu-
oroscopic times of the preoperative coil embolization
procedures were added to the fluoroscopic times of the
ESG in both groups. A comparison of these parameters
between the two groups was conducted. Student t test was
used to analyze the means. The main ESG procedures in
both groups were: group 1, patients underwent coil embo-
lization of IIA, deployment of the main bifurcated device
and its limbs, together with another limb extension into
ipsilateral EIA; group 2, patients underwent deployment of
the main bifurcated device and its limbs and bell-bottom
procedure (short extension cuff within the ipsilateral CIA).
The follow-up protocol for all patients included CT
scans and plain abdominal radiography. Follow-up intervals
were 1 month, 6 months, 12 months, and yearly thereafter.
RESULTS
Two women and 23 men had an average age of 70.1
years (range, 53 to 80 years). Mean diameters of AAA and
CIA were 56.6 mm (range, 38 to 98 mm) and 21.4 mm
(range, 15 to 48 mm), respectively.
All coil embolizations of IIAs and bell-bottom proce-
dures were performed successfully. No unintentional cov-
ering of the iliac bifurcation was performed. No difference
was found between CIA diameters in the two groups. The
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 5 Kritpracha et al 875
Fig 1. A, Diagram shows devices used in bell-bottom procedure: a, main bifurcated device; b, contralateral limb; and
c, aortic extension cuff. B, Diagram shows bell-bottom procedures, unilateral or bilateral, as alternative to IIA occlusion
and device extension.
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OR time and the catheter procedure time were significantly
lower in group 2, the bell-bottom group, compared with
group 1, the coiling and extension group. However, no
significant difference was seen in fluoroscopic time between
the two groups (Table I).
Of the 15 cases in group 2, 11 cases had unilateral and
four cases had bilateral bell-bottom procedures. Mean OR
time, catheter procedure time, and fluoroscopy time were
similar between cases with unilateral and bilateral bell-
bottom procedures (Table II). The diameters of the devices
used in 15 cases (19 arteries) in group 2 were 20 mm-
diameter extension cuffs in 10 procedures and 22 mm, 24
mm, and 26 mm-diameter extension cuffs in three proce-
dures each.
With consideration of the diameter of the treated CIA,
the average diameter of the CIA treated with coiling and
extension in group 1 was 19.9 mm (range, 15 to 26 mm) in
10 cases (10 arteries). The average diameter of the CIA
treated with bell-bottom procedure in group 2 was 19.1
mm (range, 15 to 24 mm) in 19 arteries (Table I). How-
ever, there were five cases in group 2 that had contralateral
CIA aneurysms treated with coiling IIA and extension cuff
into EIA. The average diameter of the five CIA aneurysms
was 33 mm (range, 22 to 48 mm).
No perioperative type 1 endoleak, proximal or distal,
was seen. One delayed type 1 distal endoleak occurred in
group 1. The device was severely kinked in this patient, and
at 12 months, the limb contralateral to the coil and exten-
sion side pulled up into the aneurysm sac causing distal
endoleak. Insertion of a secondary endograft limb was
performed, and the distal endoleak successfully sealed.
Three type 2 endoleaks were seen with CT scan at 1 month,
one case in group 1 and two cases in group 2. Both cases in
group 2 spontaneously sealed at 6 and 12 months after
surgery. The group 1 case had a persistent small type 2
endoleak through a 3-year follow-up period; however, the
AAA diameter was unchanged at 46 mm. Follow-up exam-
ination has been scheduled at 6-month intervals with no
immediate treatment planned for this 90-year-old patient.
No device migration was found.
Two postoperative complications occurred, one from
pelvic ischemia and one related to the angiographic proce-
dure. One group 2 patient, with bell-bottom treatment of
the left CIA and coil embolization of the right IIA, had
mild right buttock pain after surgery. The symptom was not
Fig 2. Plain abdominal x-ray shows bilateral bell-bottom proce-
dure.
Fig 3. Bell-bottom procedure (left) with contralateral IIA occlu-
sion and device extension into EIA (right).
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improved at 6 months after surgery. Another adverse event
occurred in a group 2 patient who underwent preoperative
left IIA coil embolization before surgery. The patient had
atheroembolic showering to the left foot after angiography
and coiled IIA. Popliteal to common plantar artery bypass-
ing was performed to salvage the left foot. ESG with
bell-bottom treatment of the right CIA was performed 3
months later without any complications. No colonic isch-
emia and impotence occurred in this series, and no pelvic
ischemia symptoms occurred in the bell-bottom cases.
In group 2 patients who underwent bell-bottom pro-
cedures, during the follow-up period (average, 8 months;
range, 1 to 12 months), no CIA dilatation or delayed type
1 endoleak occurred. No additional procedures were nec-
essary after surgery among the bell-bottom procedure
cases. The diameters of the treated CIAs remained un-
changed.
DISCUSSION
Aortoiliac aneurysms that extend to the iliac bifurcation
make preservation of IIA patency difficult in treatment of
AAA with endovascular grafting. Although rich collaterals
exist in the pelvic circulation, interruption of the IIA to-
gether with the inferior mesenteric artery may lead to pelvic
arterial insufficiency.14,15 Overall, approximately one third
of patients with IIA occlusion have symptoms of pelvic
ischemia, and the same sequelae occur in nearly half of
bilateral IIA occlusion cases (Tables III and IV). Buttock
claudication is the most common adverse event, occurring
in 80%, with impotence in 10% and colonic ischemia in 6%
to 9% of all pelvic ischemia complications.2-7 Although
patients who undergo even unilateral IIA occlusion are at
risk for development of life-threatening sequelae,4,7,9 these
sequelae are temporary in most cases and resolve during the
follow-up period. A wide range (20% to 80%) of improve-
Table II. Group 2 bell-bottom procedures: comparison of bilateral and unilateral bell-bottom procedures
Mean CIA
diameter (mm)
Mean OR time
(min)
Mean fluoroscopy
time (min)
Mean catheter
procedure
time (min)
Bilateral bell-bottom
(n  4)
19.0  2.9 128  55 26  13 62  40
Unilateral bell-bottom
(n  11)
19.3  3.7 140  36 28  7 57  24
Table III. Incidence of pelvic ischemic symptoms after IIA occlusions in published data
Authors
Total
IIA
occlusion
cases
Pelvic ischemic symptoms cases
Ischemic cases
(% of total)
Buttock
claudication
Sexual
dysfunction
Colonic
ischemia Other
Mehta2 154 71 (46%) 56 9 4 2 minor neuro deficit
Criado3 39 6 (15%) 5 1 0
Yano4 103 22 (21%) 21 NA† 1
Lee5 27 7 (26%) 5 1 0 1 nonhealing sacral ulcer
Razavi6 32 12 (38%) 9 2 0 1 urinary retention
Karch7 22 10 (42%) 7 NA* 3
Total 377 128 (34%) 103 (81%) 13 (10%) 8 (6%) 4 (3%)
*Did not include in data.
†Impotence and severe buttock claudication were classified in same group (classification 2 severity).
NA, Not applicable.
Table I. Comparison of CIA diameters and procedural times between two groups
Mean CIA
diameter (mm)
Mean OR time
(min)
Mean fluoroscopy
time (min)
Mean catheter
procedure
time (min)
Group 1: extension to EIA
(n  10)
19.9  3.7 192  61 43  16 106  53
Group 2: bell-bottom
(n  15)
19.1  3.4 137  40 35.0  17 58  28
P value (t test) .63 .02 .26 .02
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ment in buttock claudication symptoms has been reported
during follow-up periods up to 3 years.2-7 Colonic ischemia
necessitating laparotomy or resulting in death is rare but
has occurred.4,7
Alternative treatments have been proposed to avoid
such risks. Parodi and Ferreira11 proposed the relocation of
IIA as an alternative to IIA occlusion to preserve pelvic
blood flow, and Karch et al12 first reported the bell-bottom
technique. In the series from Karch et al, the bell-bottom
procedure allowed treatment of ectatic CIA, those with
diameters 15 to 20 mm, with a short aortic extension cuff,
diameter 20 to 24 mm, thus preserving patency of IIA.
They treated 14 patients and 18 ectatic arteries with aortic
extension cuffs. They reported no complications, and CIA
diameter did not change in 11 arteries, whereas it increased
by 1 mm in four CIAs and decreased by 1 mm in three
CIAs. The authors concluded that the bell-bottom tech-
nique is an acceptable option for the management of ectatic
iliac vessels during ESG. We cannot currently justify use of
the bell-bottom technique for large (26 mm) CIA aneu-
rysms because the largest aortic cuff device commercially
available is 28 mm. As devices evolve, this threshold may
increase, but the increased rupture risk in CIA of more than
30 mm must be considered.16 Furthermore, the bell-bot-
tom technique is not appropriate for the rare occasion when
internal iliac aneurysms are present. Internal iliac aneurysms
must still be excluded with coil embolization or repaired
with conventional open surgery to avoid rupture.
In this report, we reviewed our experience in patients
with AAA and dilated CIA treated with either the bell-
bottom technique or endograft extension across the iliac
bifurcation with coil embolization. A significant number of
patients had AAA (30%; 15 cases, 19 arteries) with dilated
CIA necessitating some therapy to allow endografting.
Both the bell-bottom procedure and IIA occlusion with
endograft extension were effective adjuncts to ESG in the
immediate perioperative period because no patient had a
type 1 endoleak. However, some advantages were observed
in the bell-bottom group, including significantly decreased
OR time and catheter procedure time (Table I).
No short-term perioperative complications were found
in the bell-bottom group: no pelvic ischemic symptoms,
type 1 endoleak, device migration, or need of a secondary
procedure. The 37.5 mm-long aortic cuff used in our study
allowed 20 mm to be telescoped into the endograft limb
with 15 to 17.5 mm remaining in apposition to the artery.
Although no late endoleak or graft disconnect failure oc-
curred at this junction during our short follow-up period,
past experience has shown the importance of diligent sur-
veillance in all patients treated with endovascular therapy.17
One IIA occlusion case in our series had mild buttock
claudication with symptoms unchanged at 6 months, and
one patient had distal embolism that necessitated limb
salvage bypass. No change was found in CIA diameter
during the follow-up period (average, 8 months; range, 1
to 12 months). Although small CIA aneurysms were ex-
cluded from the series by Karch et al,12 we treated small
CIA aneurysms (six cases with diameters between 21 and
24 mm) with the bell-bottom technique with extension
cuff devices up to 26 mm. As reported by Santilli, Werns-
ing, and Lee,16 small CIA aneurysms (30 mm) rarely
cause symptoms or rupture and expand extremely slowly.
Sequential coil embolization of bilateral IIAs has been
suggested to allow increase of pelvic collateral branches
with time. The interval between procedures varies from 2
days3 to 3 weeks4 and averaged 17 days in our series for
preoperative coil embolization. Nonetheless, the preoper-
ative IIA coil embolization itself carries an uncertain mor-
bidity risk besides pelvic ischemia, such as iliac artery dis-
section, distal emboli, groin hematoma, or failed
procedure.3 One of our cases had limb-threatening isch-
emia from emboli after preoperative IIA coil embolization
necessitating limb salvage, popliteal to common plantar
artery bypass. However, performance of the bilateral bell-
bottom procedure eliminates the need for a staged proce-
dure together with the need to occlude bilateral IIAs,
hence, avoiding pelvic ischemia and other angiographic
related complications. Furthermore, the bilateral bell-bot-
tom procedure appears not to complicate or increase OR
time, procedure time, or fluoroscopic time compared with
unilateral procedure (Table II).
Long-term results of dilated CIA treated with the bell-
bottom technique remain to be fully understood. In our
experience, after devices to perform the bell-bottom pro-
Table IV. Incidence of pelvic ischemic symptoms after bilateral IIA occlusions in published data
Authors
Total bilateral
IIA occlusion
cases
Pelvic ischemic symptoms cases
Ischemic cases
(% of total)
Buttock
claudication
Sexual
dysfunction
Colonic
ischemia
Mehta2 20 10 (50%) 8 2 0
Criado3 11 0 0 0 0
Yano4 11 6 (55%) 6 NA 0
Lee5 3 1 (33%) 1 0 0
Razavi6 7 4 (57%) 3 1 0
Karch7 2 2* (100%) 2 NA 2
Total 54 23 (43%) 20 (87%) 3 (13%) 2 (9%)
*Buttock claudication and colonic ischemia developed in both cases.
NA, Not applicable.
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cedure (group 2 cases) became available, a tendency to treat
smaller CIA aneurysms (average, 19.1 mm; range, 15 to 24
mm) with the bell-bottom procedure and larger CIA aneu-
rysms (average, 33 mm; range, 22 to 48 mm) with IIA coil
embolization with limb extension was seen. No bilateral
IIA occlusion case was performed in our series.
Some important factors need to be considered if IIA
occlusion is to be performed. The technique for coil embo-
lization of IIA to minimize pelvic ischemia is to occlude the
main trunk of IIA, preserving the patency of more distal
branches.2,3,5 Cynamon et al18 reported that when coils
were placed at or in the bifurcation of IIA, 12 of 22 (55%)
had claudication. When coils were placed in the proximal
IIA, one of 10 (10%) claudicated. Comorbid factors, such
as shock and distal embolization, also may play a significant
role in these complications.2,4
In conclusion, the bell-bottom procedure allows com-
plete exclusion of AAA in patients with ectatic and small
CIA aneurysms (26 mm) without sacrificing IIA. We did
not observe pelvic ischemia related to the bell-bottom
procedure. The bell-bottom procedure appears to have
limitations in bilateral large CIA aneurysms because of
device availability (up to 28 mm) and rupture risk. Open
surgery is still the standard treatment for repair of large and
complicated CIA aneurysms and IIA aneurysms associated
with AAA. Early technical success appears to justify contin-
ued use of the bell-bottom procedure; however, long-term
evaluation is necessary to determine durability because the
risk of rupture as the result of potential expansion of the
excluded iliac artery or late failure is unknown.
We thank Steven Gale, MD, for providing manuscript
illustrations and Jack Stedman, MPH, for assistance with
manuscript preparation.
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DISCUSSION
Dr Jon Matsumura (Chicago, Ill). I enjoyed that presenta-
tion. I think that this is very useful. I had two questions. One is,
with an 8-month average follow-up period, how confident are you
in the durability of this procedure, since we know that with large
aneurysms one of the late modes of failures is a pull-out phenom-
enon of the iliac limb up craniad into the aneurysm?
You mentioned that the largest AneuRx cuff is a 28. That is the
nominal diameter of the cuff. Do you know what is the actual
diameter of the graft material?
Dr Boonprasit Kritpracha. Regarding the first question, we
are very cautious about using this technique in the common iliac
artery or small common iliac artery aneurysm. We follow these
cases very closely, and we will have them follow-up every 6 months.
In including the patients into the treatment, we are trying not to
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use this procedure in healthy cases. We are trying to limit the use of
this procedure to the high-risk patient. I agree that the follow-up
time is still too short to say that there will be no complications in
the long term.
Regarding the second question about the true diameter of the
device, actually we used a 26-mm device and this was the self-
expanding device. It eventually expands to 26 as the original
diameter that we planned for.
Dr Matsumura. I think the stent does expand to that nom-
inal diameter, but the graft material does not always, which is what
you need to get the seal. I would encourage people who pick up
this technique to contact their rep about exactly what the actual
diameter of the graft material is because that could lead to a failure
to seal.
Dr Walter McCarthy (Chicago, Ill). I enjoyed your presen-
tation very much. We currently embolize the internal iliac arteries
as a separate procedure beforehand and then place the distal iliac
connection in the external iliac. This is a very attractive alternative
to the bell-bottom. Can you give me a better idea of what size
parameters you address with the bell-bottom technique?
Dr Kritpracha. The device currently available is 20 to 28
mm. We oversize 10% to 20% of the device, so the largest common
iliac artery that we put the limit for ourselves would be 25 mm at
the most because 28 would be the maximum diameter for the
device that we can use.
Dr John Hoch (Madison, Wis). I enjoyed your presentation.
I am trying to get a sense of your confidence in this technique. Say
you had a patient who had an iliac aneurysm and a contralateral
internal iliac occlusion and the common iliac aneurysm was 24 or
25 mm in diameter. Would you employ this technique, or would
you recommend an open procedure for that patient, or perhaps a
retroperitoneal approach and a handsewn common iliac anastomo-
sis in combination with the endograft?
Dr Kritpracha. It depends on the diameter of the common
iliac artery on which we plan to do the bell-bottom procedure. If
we can have the diameter of the device oversized at least 10% to
20% and the attachment zone at least 15 mm, then we feel
comfortable with the bell-bottom procedure. In many cases, the
attachment zone is very short, 10 mm or less, and in that case we
tend to do the open surgery or IIA coil embolization with limb
extension.
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